tiprankstipranks
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market

Estrella Immunopharma (ESLA) Income Statement

21 Followers

Estrella Immunopharma Income Statement

Last quarter (Q ), Estrella Immunopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Estrella Immunopharma's net income was $-1.87M. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21
Total Revenue
---
Cost of Revenue
$ 150.81K--
Gross Profit
$ -150.81K--
Operating Expense
$ 1.84M$ 1.37M$ -178.99K
Operating Income
$ -2.64M$ -1.57M$ -178.99K
Net Non Operating Interest Income Expense
$ -3.69K-$ 1.43K
Other Income Expense
$ -605.68K$ -654.07K-
Pretax Income
$ -2.04M$ -915.46K$ -247.72K
Tax Provision
$ 121.19K$ 80.65K$ -52.02K
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -2.18M$ -1.25M$ -177.56K
Basic EPS
$ -2.03$ -0.16-
Diluted EPS
$ -2.03$ -0.16-
Basic Average Shares
$ 11.48M$ 4.34M$ 1.18M
Diluted Average Shares
$ 11.48M$ 4.34M$ 1.18M
Dividend Per Share
$ 1.00--
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 1.99M$ 1.37M$ -178.99K
Net Income From Continuing And Discontinued Operation
$ -2.18M$ -996.10K$ -177.56K
Normalized Income
$ -1.52M--
Interest Expense
---
EBIT
$ -2.04M$ -915.46K$ -249.15K
EBITDA
$ -1.98M$ -915.46K$ -249.15K
Currency in USD

Estrella Immunopharma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis